Results

Total Results: 142 records

Showing results for "assess".

  1. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/hook.json
    January 01, 2023 - ": [{ "conditionExpression": "NoDDimerNoWells", "card": { "summary": "Please assess … PE risk and D-dimer before ordering a CTPA.", "detail": "It is recommended to assess the patient's … ordering a CTPA.", "detail": "Since the D-dimer level is not elevated, it is recommended to assess
  2. cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin%20and%20NSAIDs%20V.8.pdf
    September 08, 2020 - And Yes No Assess risk and take action if necessary Possible increased risk of bleeding Is patient … Yes Start patient on proton pump inhibitor Assess risk and take action if necessary Possible increased
  3. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/CQL%20to%20CDS%20Hooks%20cards_0.txt
    January 01, 2023 - Mapping of CQL conditions to CDS Hooks cards Condition: NoDDimerNoWells Card: It is recommended to assess … Condition: NotElevatedDDimerNoWells Card: Since the D-dimer level is not elevated, it is recommended to assess
  4. cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin%20and%20SSRIs%20Graph%20V.%205.pdf
    March 11, 2019 - Warfarin Type of Antidepressant Assess … risk and take action if necessary Increased GI and non-GI bleeding risk is possible Assess risk
  5. cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
    November 11, 2019 - Yellow: Usually Avoid Combination or Minimize Risk · For Warfarin – NSAIDS rule: · Recommendation: Assess … MG Oral Tablet Naproxen sodium 550 MG Oral Tablet Omeprazole 40 MG Delayed Release Oral Capsule Assess … Patient is not on PPI or misoprostol Warfarin Sodium 4 MG Oral Tablet Sulindac 200 MG Oral Tablet N/A Assess … PPI or misoprostol Warfarin Sodium 10 MG Oral Tablet Ketorolac Tromethamine 10 MG Oral Tablet N/A Assess … PPI or misoprostol Warfarin Sodium 10 MG Oral Tablet Ketorolac Tromethamine 10 MG Oral Tablet N/A Assess
  6. cds.ahrq.gov/cedar/AHRQ_CEDAR_Final_Project_Report_09_29_2022.pdf
    January 01, 2022 - To accommodate the need to assess FAIRness, MITRE created a new tool to assess repository FAIRness, … C-FAIR adapted the FAIR Guiding Principles to assess the CEPI repositories themselves instead of the … MITRE used C-FAIR to assess the CEPI repositories four times. … MITRE and AAFP tested CEDAR in a real- world setting to assess the feasibility of its implementation … Environmental Scan Assess other CEPI, AHRQ Digital Health, and AHRQ evidence resources and programs
  7. cds.ahrq.gov/taxonomy/term/147981
    August 23, 2024 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  8. cds.ahrq.gov/cdsconnect/artifact-type/risk-assessment
    May 31, 2022 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  9. cds.ahrq.gov/cdsconnect/keywords/risk-assessment
    November 30, 2020 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  10. cds.ahrq.gov/cdsconnect/keywords/pain-assessment
    November 30, 2020 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  11. cds.ahrq.gov/taxonomy/term/2136
    May 31, 2022 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  12. cds.ahrq.gov/sites/default/files/cds/artifact/171/NIOSH_Occupational%20Factors%20Impacting%20Diabetes_Decision%20Log_condensed.pdf
    February 01, 2018 - at risk of harm (safety sensitive occupations) “current job(s)” The intent of the guideline is to assess … ability to take breaks”, “ability to eat/drink/take medication” These statements are intended to assess
  13. cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
    January 01, 2017 - period of 6 years for the LDL-c laboratory result, citing the 2013 ACC/AHA guideline recommendation to assess … lookback period of 6 years for the BP measurements, citing the 2013 ACC/AHA guideline recommendation to assess
  14. cds.ahrq.gov/sites/default/files/Lessons%20Learned%20Summary%20Sheet%20CDS%20Connect%20Patient%20Partnering%20Panel%202021.pdf
    April 15, 2022 - Self-assess where you and yours live on the continuums of partnership and co-production.
  15. cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
    August 29, 2020 - Usually Avoid Combination or Minimize Risk · For Warfarin – Antidepressants rule: · Recommendation: Assess … Mirtazapine Warfarin Sodium 10 MG Oral Tablet Mirtazapine 45 MG Disintegrating Oral Tablet N/A Assess … major bleeding risk factors Warfarin Sodium 10 MG Oral Tablet Escitalopram 20 MG Oral Tablet None Assess … major bleeding risk factors Warfarin Sodium 10 MG Oral Tablet Escitalopram 20 MG Oral Tablet None Assess
  16. cds.ahrq.gov/sites/default/files/cds/artifact/106/Poster_AAPNCE_10.26.15.pptx
    October 13, 2015 - We developed a 62-item questionnaire to assess clinicians’ perspectives on their roles in the evaluation
  17. cds.ahrq.gov/cedar/AHRQ_CEDAR_Terms_and_Conditions.pdf
    September 28, 2022 - Logs may be accessed and analyzed by Operators to assess the performance of CEDAR and plan future work
  18. cds.ahrq.gov/cdsconnect/artifact/recommendation-7-opioid-therapy-risk-assessment
    September 27, 2018 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  19. cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 01/11/2017 Time 3:00 – 5:00 PM ET AGENDA · Welcome and introductions · Discuss ACC/AHA 10-Year ASCVD Risk Assessment Tool Metadata and CDS creation · Discuss Longitudinal Risk Assessment Tool Metadata, CDS Creation and Shared Decision Making · Questions to…
  20. cds.ahrq.gov/cedar/AHRQ_CEDAR_Environmental_Scan_2020_508.pdf
    January 01, 2020 - To assess the feasibility of this type of integration, the team investigated the web site search form … at http://web.archive.org/web/20160101002421/http://guideline.gov/. 15 • Methods Used to Assess … o I ‒ The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits … This lack of definition, however, means that many of the existing tools that were developed to assess … The GRADE system defines a quantitative framework to assess the quality of clinical evidence and strength

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: